MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) announces an educational webinar exploring the evolution of PSMA1-targeted radionuclide therapy and Telix’s differentiated, multi-product approach to treating prostate cancer across the disease continuum. Dr. David N. Cade, Telix Group Chief Medical Officer will host a discussion with Professor Louise Emmett, Director of Theranostics and Nuclear Medicine at St Vincent’s Ho ...

CALGARY, Alberta, April 27, 2026 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT”, the “Company”, “we”, “our”, “us” or “ours”) (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, announced today that it will release its first quarter 2026 financial results on Wednesday, May 6, 2026, after markets close. Webcast Information:In conjunction with the release, the executive team has scheduled a conference call to discuss the company’s results. The call will be broadcast live via web ...

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XII (the “Company”) announced the pricing of its upsized initial public offering of 36,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “CXIIU” commencing today. Each unit consists of one Class A ordinary share of the Company and one-tenth of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exe ...

文章核心观点 MiniLuxe Holding Corp. 在2025财年实现了创纪录的业绩，其核心战略支柱均取得重大进展。公司通过专注于单店经济模型的持续改善、扩大运营合作伙伴网络、提升门店层面盈利能力以及优化成本结构，实现了系统销售额、单店平均营业额（AUV）和门店层面盈利能力的显著增长。尽管公司整体仍处于运营亏损状态，但亏损额已收窄，现金状况得到改善，并获得了新的融资以支持未来的扩张计划[1][5][7]。 --- 业务与战略表现 整体业绩亮点 - 2025财年系统销售额达到2900万美元，同比增长11%；公司自营工作室收入为2800万美元，有机增长7%[7]。 - 单店平均营业额从120万美元提升至130万美元[7]。 - 门店层面总盈利能力（门店现金贡献）同比增长50%[7]。 - 公司运营亏损减少8%，即60万美元，从上年的-680万美元收窄至-620万美元[7]。 - 年末现金、现金等价物及受限现金达到450万美元，较2024财年末的400万美元增加50万美元[7]。 - 店内零售销售额同比增长50%，得益于公司自有畅销产品（如手部焕新乳）的重新推出[7]。 核心战略支柱进展 - **通过运营和特许经营伙伴推动增长**：公司在2025年下半年签署了两项新的合资伙伴关系，以扩大在达拉斯-沃斯堡的现有业务并进入康涅狄格州费尔菲尔德县市场。目标是在未来12-18个月在这些区域开设多家新工作室[10]。 - **加速提升门店层面盈利能力**：通过对门店经理进行关键绩效指标（KPI）和结构化发展计划的重点管理，实现了门店现金贡献的强劲增长[7]。 - **提高固定成本杠杆和SG&A效率**：公司销售、一般及行政管理费用同比增长13%至1490万美元，主要受股权激励费用、资产处置等非现金支出，以及重建公司团队的一次性招聘和人力资源费用驱动[7]。 - **扩大网络与收购**：2025年8月，公司收购了达拉斯-沃斯堡一家地理位置优越的美甲沙龙，以此进入Lakewood社区新市场。该店目前正在改造中，预计于2026年第二季度以MiniLuxe工作室重新开业。公司还在马萨诸塞州和康涅狄格州确定了新店址[8]。 运营指标与效率 - 毛利率保持稳定，为42%。公司继续在需求到来前投资于员工工时和店内培训以提升服务水平[9]。 - 表现最好的前25%门店已实现200万美元的AUV，盈利能力最强的门店平均利润率达到20%。按平均约1600平方英尺的面积计算，相当于每平方英尺1250美元的营收[9]。 - 公司实现了连续12个季度的单店经济模型改善[4][11]。 - 公司拥有约85%的年度人才保留率，这一指标在过去三年中持续保持优异水平[3][11]。 --- 财务业绩摘要 收入与利润 - **总收入**：2790.3万美元，较上年的2612.1万美元增长7%[17]。 - **服务收入**：2768.0万美元，同比增长8%[17]。 - **产品收入**：22.3万美元，同比下降43%[17]。 - **毛利润**：1165.1万美元，同比增长6%[17]。 - **毛利率**：42%，与上年持平[17]。 - **运营亏损**：623.8万美元，较上年的680.0万美元减少8.2%[19]。 - **净亏损**：831.8万美元，较上年的886.7万美元有所收窄[19]。 - **调整后税息折旧及摊销前利润**：-436.3万美元，较上年的-408.9万美元下降7%[17][27]。 现金流 - **经营活动现金流**：净流出253.3万美元[21]。 - **投资活动现金流**：净流入5.7万美元[21]。 - **融资活动现金流**：净流入295.2万美元[21]。 - **现金净流入**：47.6万美元，年末现金及相关余额增至450万美元[7][21]。 --- 后续事件与近期动态 融资进展 - 2026年4月1日，Flow Capital Corporation根据现有定期贷款协议完成了高达175万美元的后续投资。初始预付款135万美元已到位，公司有权在满足特定融资里程碑后额外提取40万美元，预计这些里程碑将全部达成[13]。 - 截至2026年4月24日，公司已获得TSXV有条件批准，可完成350万至500万美元的私募配售。公司已签署了总额超过350万美元的认购协议[14]。 品牌与营销 - 2026年4月13日，公司宣布任命2026年NCAA冠军、WNBA多伦多节奏队首轮选秀球员Kiki Rice为首位品牌大使。合作期间，Rice在NCAA锦标赛中展示了两款定制的MiniLuxe甲片[15]。 --- 公司背景与行业定位 - MiniLuxe是一个生活方式品牌和平台，通过超卫生实践、更健康的产品和以人才为先的模式，提供高质量美甲和美容服务[3]。 - 公司致力于经济赋能，已支付超过1.75亿美元的行业领先公平工资，提供健康和401k福利，培训了数千名美甲设计师[3]。 - 公司旨在通过其品牌、标准和技术平台，彻底改变高度分散且监管不足的自我护理和美甲护理行业，成为美甲护理专业人士的首选雇主[28]。 - 自成立以来，公司已在多个州的工作室提供了超过500万次服务[3][28]。

Perth, April 28, 2026 (GLOBE NEWSWIRE) -- First Stoping Operations at CMA Underground in Côte d’Ivoire Overview Perth, Western Australia/April 28, 2026/Perseus Mining Limited (ASX/TSX: PRU) is pleased to announce it has successfully completed the first underground production blast at its CMA Underground project. The blast was fired from Blika 1120 Ore Drive South at the Yaouré Gold Mine in Côte d’Ivoire, with excavation of the first production ore commenced immediately. This event is a key milestone for the ...

RANCHO CORDOVA, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the “Bank”), today reported net income of $18.6 million for the three months ended March 31, 2026, as compared to $17.6 million for the three months ended December 31, 2025 and $13.1 million for the three months ended March 31, 2025. First Quarter Highlights Performance and operating highlights ...

VANCOUVER, British Columbia, April 27, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, is pleased to announce that it will be reporting its financial results for the period ended March 31, 2026 (“Q1 2026”) after market close on Wednesday May 13, 2026. The Company also advises that it has entered into an amendment to tempo ...

Revenues of $2.05 billionNet income of $19 million, or $0.05 per shareAdjusted EBITDA* of $177 millionBookings of $520 million, representing a book-to-bill of 80%Returned $100 million of capital to shareholders through share repurchases and dividends *Free Cash Flow, Excess Free Cash Flow, Adjusted Operating Profit, and Adjusted EBITDA are non-GAAP measures, see “Non-GAAP Financial Measures,” and “Reconciliation of GAAP to non-GAAP measures” below. HOUSTON, April 27, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE ...

CARY, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, May 11, 2026, at 8:30 a.m. ET to report first quarter 2026 financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To av ...

Oral and poster presentations highlight progress across cardiac genetic medicine pipeline and optimized, Sf9-baculovirus AAV manufacturing platformNEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its cardiac gene therapy programs and optimized AAV manufacturing approach will be presented at the 29th Annual Meeting of the ...